Epigenetic Priming Confers Direct Cell Trans-Differentiation From Adipocyte to Osteoblast in a Transgene-Free State

Journal of Cellular Physiology

Volumn 231, Issue 7, 2016, Pages 1484-1494

  Cho, Young Dan ^a   Bae, Han Sol ^a   Lee, Dong Seol ^a   Yoon, Won Joon ^a   Woo, Kyung Mi ^a   Baek, Jeong Hwa ^a   Lee, Gene ^a   Park, Joo Cheol ^a   Ku, Young ^a   Ryoo, Hyun Mo ^a  

^a Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DECITABINE; WNT3A PROTEIN; 5'-AZACYTIDINE 5'-MONOPHOSPHATE; CYTIDINE PHOSPHATE; DNA (CYTOSINE 5) METHYLTRANSFERASE; WNT3A PROTEIN, MOUSE;

3T3 CELL LINE; ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DEVELOPMENT; CELL TRANSDIFFERENTIATION; CONTROLLED STUDY; CPG ISLAND; DEMETHYLATION; DNA METHYLATION; EPIGENETICS; FEMALE; GENE EXPRESSION; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEAR REPROGRAMMING; OSSIFICATION; OSTEOBLAST; OSTEOPOROSIS; PRIORITY JOURNAL; TISSUE ENGINEERING; ANALOGS AND DERIVATIVES; ANIMAL; CYTOLOGY; DRUG EFFECTS; GENETIC EPIGENESIS; GENETICS; HUMAN; METABOLISM;

ADIPOCYTES; ANIMALS; CELL TRANSDIFFERENTIATION; CYTIDINE MONOPHOSPHATE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; EPIGENESIS, GENETIC; HUMANS; MICE; OSTEOBLASTS; OSTEOGENESIS; WNT3A PROTEIN;

EID: 84951310977     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.25183     Document Type: Article

References (56)

1. Banerjee C, Javed A, Choi JY, Green J, Rosen V, van Wijnen AJ, Stein JL, Lian JB, Stein GS. 2001. Differential regulation of the two principal Runx2/Cbfa1 n-terminal isoforms in response to bone morphogenetic protein-2 during development of the osteoblast phenotype. Endocrinology 142:4026-4039.
2. Baron R, Kneissel M. 2013. WNT signaling in bone homeostasis and disease: From human mutations to treatments. Nat Med 19:179-192.
3. Bowers RR, Kim JW, Otto TC, Lane MD. 2006. Stable stem cell commitment to the adipocyte lineage by inhibition of DNA methylation: Role of the BMP-4 gene. Proc Natl Acad Sci USA 103:13022-13027.
4. Camilleri S, McDonald F. 2006. Runx2 and dental development. Eur J Oral Sci 114:361-373.
5. Cedar H. 1988. DNA methylation and gene activity. Cell 53:3-4.
6. Cedar H, Bergman Y. 2009. Linking DNA methylation and histone modification: Patterns and paradigms. Nat Rev Genet 10:295-304.
7. Cho YD, Kim WJ, Yoon WJ, Woo KM, Baek JH, Lee G, Kim GS, Ryoo HM. 2012. Wnt3a stimulates Mepe, matrix extracellular phosphoglycoprotein, expression directly by the activation of the canonical Wnt signaling pathway and indirectly through the stimulation of autocrine Bmp-2 expression. J Cell Physiol 227:2287-2296.
8. Cho YD, Yoon WJ, Kim WJ, Woo KM, Baek JH, Lee G, Ku Y, van Wijnen AJ, Ryoo HM. 2014. Epigenetic modifications and canonical Wingless/int-1 Class (WNT) signaling enable trans-differentiation of nonosteogenic cells into osteoblasts. J Biol Chem 289:20120-20128.
9. Cho YD, Yoon WJ, Woo KM, Baek JH, Lee G, Cho JY, Ryoo HM. 2009. Molecular regulation of matrix extracellular phosphoglycoprotein expression by bone morphogenetic protein-2. J Biol Chem 284:25230-25240.
10. Delgado-Calle J, Garmilla P, Riancho JA. 2012. Do epigenetic marks govern bone mass and homeostasis? Curr Genomics 13:252-263.
11. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. 1997. Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell 89:747-754.
12. Eguizabal C, Montserrat N, Veiga A, Izpisua Belmonte JC. 2013. Dedifferentiation, transdifferentiation, and reprogramming: Future directions in regenerative medicine. Semin Reprod Med 31:82-94.
13. Ezura Y, Sekiya I, Koga H, Muneta T, Noda M. 2009. Methylation status of CpG islands in the promoter regions of signature genes during chondrogenesis of human synovium-derived mesenchymal stem cells. Arthritis Rheum 60:1416-1426.
14. Fajas L, Auboeuf D, Raspe E, Schoonjans K, Lefebvre AM, Saladin R, Najib J, Laville M, Fruchart JC, Deeb S, Vidal-Puig A, Flier J, Briggs MR, Staels B, Vidal H, Auwerx J. 1997. The organization, promoter analysis, and expression of the human PPARgamma gene. J Biol Chem 272:18779-18789.
15. Ferrari SL. 2005. Osteoporosis: A complex disorder of aging with multiple genetic and environmental determinants. World Rev Nutr Diet 95:35-51.
16. Gardiner-Garden M, Frommer M. 1987. CpG islands in vertebrate genomes. J Mol Biol 196:261-282.
17. Garg V, Kathiriya IS, Barnes R, Schluterman MK, King IN, Butler CA, Rothrock CR, Eapen RS, Hirayama-Yamada K, Joo K, Matsuoka R, Cohen JC, Srivastava D. 2003. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 424:443-447.
18. Gaur T, Lengner CJ, Hovhannisyan H, Bhat RA, Bodine PV, Komm BS, Javed A, van Wijnen AJ, Stein JL, Stein GS, Lian JB. 2005. Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J Biol Chem 280:33132-33140.
19. Ge K. 2012. Epigenetic regulation of adipogenesis by histone methylation. Biochim Biophys Acta 1819:727-732.
20. Goldberg AD, Allis CD, Bernstein E. 2007. Epigenetics: A landscape takes shape. Cell 128:635-638.
21. Graf T, Enver T. 2009. Forcing cells to change lineages. Nature 462:587-594.
22. Harvey N, Dennison E, Cooper C. 2008. Epidemiology of osteoporotic fracture. In: Favus MJ, editor. Primer on the metabolic bone diseases and disorders of mineral metabolism, 7th edition. ASBMR: John Wiley & Sons, Inc. pp 198-203.
23. Holroyd C, Harvey N, Dennison E, Cooper C. 2012. Epigenetic influences in the developmental origins of osteoporosis. Osteoporos Int 23:401-410.
24. Ieda M, Fu JD, Delgado-Olguin P, Vedantham V, Hayashi Y, Bruneau BG, Srivastava D. 2010. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142:375-386.
25. Jaenisch R, Young R. 2008. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 132:567-582.
26. Jones PL, Veenstra GJ, Wade PA, Vermaak D, Kass SU, Landsberger N, Strouboulis J, Wolffe AP. 1998. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet 19:187-191.
27. Justesen J, Stenderup K, Ebbesen EN, Mosekilde L, Steiniche T, Kassem M. 2001. Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology 2:165-171.
28. Kawai M, Mushiake S, Bessho K, Murakami M, Namba N, Kokubu C, Michigami T, Ozono K. 2007. Wnt/Lrp/beta-catenin signaling suppresses adipogenesis by inhibiting mutual activation of PPARgamma and C/EBPalpha. Biochem Biophys Res Commun 363:276-282.
29. Khochbin S, Nonchev S. 2009. Preface to the "epigenetics and development" special issue. Int J Dev Biol 53:189-190.
30. Kim M, Kim C, Choi YS, Kim M, Park C, Suh Y. 2012. Age-related alterations in mesenchymal stem cells related to shift in differentiation from osteogenic to adipogenic potential: Implication to age-associated bone diseases and defects. Mech Ageing Dev 133:215-225.
31. Kim YJ, Lee MH, Wozney JM, Cho JY, Ryoo HM. 2004. Bone morphogenetic protein-2-induced alkaline phosphatase expression is stimulated by Dlx5 and repressed by Msx2. J Biol Chem 279:50773-50780.
32. Kirton JP, Crofts NJ, George SJ, Brennan K, Canfield AE. 2007. Wnt/beta-catenin signaling stimulates chondrogenic and inhibits adipogenic differentiation of pericytes: Potential relevance to vascular disease? Circ Res 101:581-589.
33. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T. 1997. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755-764.
34. Krishnan V, Bryant HU, Macdougald OA. 2006. Regulation of bone mass by Wnt signaling. J Clin Invest 116:1202-1209.
35. Kubota T, Michigami T, Ozono K. 2009. Wnt signaling in bone metabolism. J Bone Miner Metab 27:265-271.
36. Kung AW, Huang QY. 2007. Genetic and environmental determinants of osteoporosis. J Musculoskelet Neuronal Interact 7:26-32.
37. Lee JE, Ge K. 2014. Transcriptional and epigenetic regulation of PPARgamma expression during adipogenesis. Cell Biosci 4:29.
38. Lee MH, Kim YJ, Yoon WJ, Kim JI, Kim BG, Hwang YS, Wozney JM, Chi XZ, Bae SC, Choi KY, Cho JY, Choi JY, Ryoo HM. 2005. Dlx5 specifically regulates Runx2 type II expression by binding to homeodomain-response elements in the Runx2 distal promoter. J Biol Chem 280:35579-35587.
39. Li HX, Luo X, Liu RX, Yang YJ, Yang GS. 2008. Roles of Wnt/beta-catenin signaling in adipogenic differentiation potential of adipose-derived mesenchymal stem cells. Mol Cell Endocrinol 291:116-124.
40. Li LC, Dahiya R. 2002. MethPrimer: Designing primers for methylation PCRs. Bioinformatics 18:1427-1431.
41. Lin Q, Schwarz J, Bucana C, Olson EN. 1997. Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science 276:1404-1407.
42. Lips P, van Schoor NM. 2005. Quality of life in patients with osteoporosis. Osteoporos Int 16:447-455.
43. Meivar-Levy I, Sapir T, Gefen-Halevi S, Aviv V, Barshack I, Onaca N, Mor E, Ferber S. 2007. Pancreatic and duodenal homeobox gene 1 induces hepatic dedifferentiation by suppressing the expression of CCAAT/enhancer-binding protein beta. Hepatology 46:898-905.
44. Mohn F, Schubeler D. 2009. Genetics and epigenetics: Stability and plasticity during cellular differentiation. Trends Genet 25:129-136.
45. Park MH, Shin HI, Choi JY, Nam SH, Kim YJ, Kim HJ, Ryoo HM. 2001. Differential expression patterns of Runx2 isoforms in cranial suture morphogenesis. J Bone Miner Res 16:885-892.
46. Rosen ED, Sarraf P, Troy AE, Bradwin G, Moore K, Milstone DS, Spiegelman BM, Mortensen RM. 1999. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell 4:611-617.
47. Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, Erickson RL, MacDougald OA. 2000. Inhibition of adipogenesis by Wnt signaling. Science 289:950-953.
48. Sakamoto H, Kogo Y, Ohgane J, Hattori N, Yagi S, Tanaka S, Shiota K. 2008. Sequential changes in genome-wide DNA methylation status during adipocyte differentiation. Biochem Biophys Res Commun 366:360-366.
49. Schilling T, Noth U, Klein-Hitpass L, Jakob F, Schutze N. 2007. Plasticity in adipogenesis and osteogenesis of human mesenchymal stem cells. Mol Cell Endocrinol 271:1-17.
50. Takada I, Kouzmenko AP, Kato S. 2009. Wnt and PPARgamma signaling in osteoblastogenesis and adipogenesis. Nat Rev Rheumatol 5:442-447.
51. Takahashi T. 2011. Overexpression of Runx2 and MKP-1 stimulates transdifferentiation of 3T3-L1 preadipocytes into bone-forming osteoblasts in vitro. Calcif Tissue Int 88:336-347.
52. Taylor SM, Jones PA. 1979. Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine. Cell 17:771-779.
53. Vrtacnik P, Marc J, Ostanek B. 2014. Epigenetic mechanisms in bone. Clin Chem Lab Med 52:589-608.
54. Xiao ZS, Liu SG, Hinson TK, Quarles LD. 2001. Characterization of the upstream mouse Cbfa1/Runx2 promoter. J Cell Biochem 82:647-659.
55. Zhu Y, Qi C, Korenberg JR, Chen XN, Noya D, Rao MS, Reddy JK. 1995. Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: Alternative promoter use and different splicing yield two mPPAR gamma isoforms. Proc Natl Acad Sci USA 92:7921-7925.
56. Zilber S, Epstein NJ, Lee SW, Larsen M, Ma T, Smith RL, Biswal S, Goodman SB. 2008. Mouse femoral intramedullary injection model: Technique and microCT scan validation. J Biomed Mater Res B Appl Biomater 84:286-290.